Indivior (INDV)
(Real Time Quote from BATS)
$10.14 USD
-0.05 (-0.49%)
Updated Jul 10, 2024 02:16 PM ET
4-Sell of 5 4
B Value F Growth B Momentum D VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Bottom 38% (154 out of 250)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.52 | 9.99 |
Current Quarter Estimate | 0.38 | 0.39 | 61.00 |
Year Ago Quarter Estimate | 0.39 | -0.79 | 54.84 |
Next Quarter Estimate | 0.43 | -2.04 | 63.00 |
Next Year Estimate | 2.49 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 22.93 | 14.00 | 15.67 |
Next Year | 29.02 | 15.00 | 9.31 |
Last 5 Years | -0.20 | 7.00 | 8.10 |
Next 5 Years | NA | 25.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 6.66 | -5.88 |
Price/Book (MRQ) | 140.50 | 1.67 |
Price/Cash Flow (MRFY) | 5.60 | 8.16 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 0.44% | -2,822.50% |
Return on Equity (TTM) | 842.72% | -71.77% |
Debt to Equity (MRQ) | NA | 0.08 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.